Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 May-Jun;17(3):594-601.
doi: 10.1097/gme.0b013e3181c92134.

Appetitive hormones, but not isoflavone tablets, influence overall and central adiposity in healthy postmenopausal women

Oksana A Matvienko  1 , D Lee Alekel, Ulrike Genschel, Laura Ritland, Marta D Van Loan, Kenneth J Koehler
Affiliations
Randomized Controlled Trial

Appetitive hormones, but not isoflavone tablets, influence overall and central adiposity in healthy postmenopausal women

Oksana A Matvienko et al. Menopause. 2010 May-Jun.

Abstract

Objective: One of the multiple health benefits of soy protein or its isoflavones may be their purported favorable effect on body composition. We examined the effect of isoflavones extracted from soy protein on overall and regional body composition, taking into account appetitive hormones as potential mediators, as well as the direct effect on appetitive hormones.

Methods: This randomized, double-blind, placebo-controlled multicenter trial included 229 healthy postmenopausal women (age, 45.8-65 y; body mass index, 24.9 +/- 3.0 kg/m) who consumed placebo or soy isoflavone (80 or 120 mg/d) tablets for 12 months. We used intent-to-treat analysis to examine changes in body composition (whole-body lean mass, whole-body fat mass, androidal fat mass, and androidal-to-gynoidal fat mass ratio) and appetitive hormones (insulin, leptin, ghrelin, and adiponectin) in response to treatment.

Results: Repeated-measures analysis of variance indicated that soy isoflavone treatment did not exert a significant effect on body composition measures (P value from 0.36 to 0.79) or appetitive hormone concentrations; the inclusion of covariates in statistical models did not alter these results. Independently of treatment, leptin and ghrelin related inversely to each body composition measure (P values from 0.044 to < or = 0.0001). Adiponectin related inversely to all fat measures (P values from 0.0004 to <0.0001). Time since last menstrual period related directly to all fat measures (P values from 0.06 to 0.0055). Dietary fat contributed to whole-body (P = 0.028) and androidal (P = 0.017) fat mass.

Conclusions: Our findings do not support a favorable effect of soy isoflavone tablets on body composition in healthy postmenopausal women.

Trial registration: ClinicalTrials.gov NCT00043745.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have no conflicts of interest.

Conflicts of Interest/Financial Disclosures: Coauthors have not reported any conflicts or disclosures.

Figures

FIGURE 1
FIGURE 1. Participant Screening and Enrollment Flow Chart
Transvaginal ultrasound (TVU), lost-to-follow-up (LTFU) We excluded 13 women at UCD from this analysis because they did not meet entry criteria and were deemed protocol violators (11 due to a thickened endometrium, 1 with breast cancer, 1 without a baseline blood sample). In addition, 13 women (11 at UCD, 2 at ISU) had missing body composition data at 6 and/or 12 month (mo) time points because they were lost to follow-up and thus excluded from the analysis. Three women discontinued treatment, but completed the trial; their data were included in the analysis.
See this image and copyright information in PMC

References

    1. Hanson KB, Song TT, Peterson CT, et al. Daidzein exerts a marked effect on body composition in male hamsters. Presented at the 3rd International Symposium on the Role of Soy in Preventing and Treating Chronic Diseases; October 31–November 3, 1999; Washington DC., USA.
    1. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr. 1996:161–7. - PubMed
    1. Szkudelska K, Nogowski L. Genistein – a dietary compound inducing hormonal and metabolic changes. J Steroid Biochem Mol Biol. 2007;105:37–45. - PubMed
    1. Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesterol ester content in ovariectomized cynomologus monkeys. Metabolism. 1997;46:698–705. - PubMed
    1. Moeller LE, Peterson CT, Hanson KB, et al. Isofavone-rich soy protein prevents loss of hip lean mass, but does not prevent the shift in regional fat distribution in perimenopausal women. Menopause. 2003;10:322–31. - PubMed

Publication types

MeSH terms

Associated data